The Osteoporosis Partnering report provides understanding and access to the osteoporosis partnering deals and agreements entered into by the worlds leading healthcare companies.
NPS Pharmaceuticals is a global pharmaceutical company treating rare diseases specifically focusing upon gastrointestinal and endocrine disorders.
Warner Chilcott is a top pharmaceutical company based in Dublin, Ireland
Abbott Laboratories is a top pharmaceutical company based in Illinois, USA
The healthcare sector in 2013 continues to adjust to a new environment of sluggish economic growth, budget constraints, reimbursement challenges, higher regulatory hurdles, and the uncertainties surrounding healthcare reform. Just recently, the European Parliament recently approved, by an overwhelming margin, a tightening up of CE-mark pre-market authorizations and post-mark surveillance of medical devices
Novartis is a top pharma company active in partnering, licensing and M&A in pharmaceuticals
Sorry, your search returned no results.
Financial terms of the partnership include an initial payment and near-term commercial milestones to Amgen totaling $120 million, and ongoing royalties. In Europe, Amgen and GlaxoSmithKline will share profits after accounting for expenses associated with the partnership. In emerging markets, GlaxoSmithKline will be responsible for all commercialization expenses and purchase denosumab from Amgen to meet more »
EffRx will receive from Nycomed additional upfront and milestone payments of up to US$15m.
EffRx will receive from Nycomed upfront and milestone payments up to $59m.
Zosano Pharma and Eli Lilly have entered into an exclusive agreement to develop ZP-PTH
Radius Health, a biotech developing treatments to restore bone loss from osteoporosis, filed on Wednesday with the SEC to raise up to $86 million in an initial public offering financing.
A pharma partners agreement was singed between Merck, a big pharma company and The Regenstrief Institute to collaborate on a range of projects that will use clinical data to inform personalized delivery of health care